Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
International Journal of Pharmaceutics
|
November 30, 2024
Unveiling tablet structural changes: A micro computed tomography analysis of aqueous coating effects
Davide D'Angelo, Eride Quarta, Gianluca Bazzoli, et al.
Drug Delivery and Translational Research
|
February 7, 2026
Engineered levothyroxine dry powder for inhalation to treat idiopathic pulmonary fibrosis
Gianluca Bazzoli, Annalisa Bianchera, Giovanna Trevisi, et al.
The Science of the Total Environment
|
September 11, 2025
Drugs as contaminants of emerging concern: preventive approaches beyond detection, regulatory aspects and remediation
Umberto Cancelli, Eride Quarta, Davide D'Angelo, et al.
Drug Delivery and Translational Research
|
April 25, 2023
Nebulizers effectiveness on pulmonary delivery of alpha-1 antitrypsin
Annalisa Bianchera, Viviana Vilardo, Roberta Giaccari, et al.
Pharmaceutics
|
December 23, 2022
Recombinant Alpha-1 Antitrypsin as Dry Powder for Pulmonary Administration: A Formulative Proof of Concept
Annalisa Bianchera, Esraa'a Alomari, Annalisa Michielon, et al.
Comparative Immunology, Microbiology and Infectious Diseases
|
August 8, 2020
An engineered anti-idiotypic antibody-derived killer peptide (KP) early activates swine inflammatory monocytes, CD3<sup>+</sup>CD16<sup>+</sup> natural killer T cells and CD4<sup>+</sup>CD8α<sup>+</sup> double positive CD8β<sup>+</sup> cytotoxic T lymphocytes associated with TNF-α and IFN-γ secretion
Luca Ferrari, Paolo Martelli, Roberta Saleri, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
International Journal of Pharmaceutics
|
November 30, 2024
Unveiling tablet structural changes: A micro computed tomography analysis of aqueous coating effects
Davide D'Angelo, Eride Quarta, Gianluca Bazzoli, et al.
Drug Delivery and Translational Research
|
February 7, 2026
Engineered levothyroxine dry powder for inhalation to treat idiopathic pulmonary fibrosis
Gianluca Bazzoli, Annalisa Bianchera, Giovanna Trevisi, et al.
The Science of the Total Environment
|
September 11, 2025
Drugs as contaminants of emerging concern: preventive approaches beyond detection, regulatory aspects and remediation
Umberto Cancelli, Eride Quarta, Davide D'Angelo, et al.
Drug Delivery and Translational Research
|
April 25, 2023
Nebulizers effectiveness on pulmonary delivery of alpha-1 antitrypsin
Annalisa Bianchera, Viviana Vilardo, Roberta Giaccari, et al.
Pharmaceutics
|
December 23, 2022
Recombinant Alpha-1 Antitrypsin as Dry Powder for Pulmonary Administration: A Formulative Proof of Concept
Annalisa Bianchera, Esraa'a Alomari, Annalisa Michielon, et al.
Comparative Immunology, Microbiology and Infectious Diseases
|
August 8, 2020
An engineered anti-idiotypic antibody-derived killer peptide (KP) early activates swine inflammatory monocytes, CD3<sup>+</sup>CD16<sup>+</sup> natural killer T cells and CD4<sup>+</sup>CD8α<sup>+</sup> double positive CD8β<sup>+</sup> cytotoxic T lymphocytes associated with TNF-α and IFN-γ secretion
Luca Ferrari, Paolo Martelli, Roberta Saleri, et al.
Page
of 1